HEALTH CARE:
BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other healthcare-related products. The Company has three segments: Pharmaceuticals, Nutritionals and ConvaTec. The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business. The other two segments Nutritionals and ConvaTec comprise the Company's Health Care Group. The Nutritionals segment consists of Mead Johnson Nutritionals (Mead Johnson), primarily an infant formula and children's nutritionals business. The ConvaTec segment consists of the ostomy, wound and skin care business.
| Market Cap | 102.736 Billion | Shares Outstanding | 1.637 Billion | Avg Volume | 12.73 Million |
| 1-Yr BETA vs S&P TR | 0.74 | Current Ratio | 1.55 | Quick Ratio | 1.43 |
| Q2 2018 | All Institutions | Hedge Funds 1 |
|---|---|---|
| To trade BMY now: | |
|
| Filers who had this stock in their top 10: | 40 | 7 (0.67%) |
| 13F Filers holding this stock: | 1634 | 128 (12.24%) |
| Aggregate 13F shares on 06/30/2018: | 1.179 Billion | 73.343 Million |
| Aggregate 13F shares on 03/31/2018: | 1.172 Billion | 71.959 Million |
| Percent change: | 0.59% | 1.92% |
| Funds creating new positions: | 91 | 16 |
| Funds Adding to an existing position: | 562 | 47 |
| Funds closing out their position: | 130 | 39 |
| Funds reducing their position: | 739 | 48 |
| Heat Map Ranking for 06/30/2018 | 122 | |
| Heat Map Ranking for 03/31/2018 | 36 | |
| 1 hedge funds as identified by whalewisdom.com through public filings. | ||
View recent insider trading info
Bristol-Myers Squibb Co Chart by YCharts
Please sign in first
none
none
2 Thousand total shares from 3 transactions
| Reporting Owners | Transaction Date | Transaction Code | Shares | Acquired or Disposed | Shares Owned Following Transaction | Direct/Indirect Ownership |
|---|---|---|---|---|---|---|
| 2018-10-02 | M | 592 | a | 592 | direct | |
| 2018-10-02 | M | 592 | d | 1,776 | direct | |
| 2018-10-02 | F | 292 | d | 300 | direct | |
| 2018-09-30 | A | 524 | a | 14,136 | direct | |
| 2018-09-30 | A | 524 | a | 43,493 | direct | |
| 2018-09-30 | A | 386 | a | 3,681 | direct | |
| 2018-09-30 | A | 282 | a | 74,076 | direct | |
| 2018-09-30 | A | 493 | a | 8,395 | direct | |
| 2018-09-30 | A | 524 | a | 9,439 | direct | |
| 2018-09-30 | A | 493 | a | 64,079 | direct | |
| 2018-09-30 | A | 493 | a | 21,707 | direct | |
| 2018-09-30 | A | 524 | a | 43,493 | direct | |
| 2018-09-30 | A | 126 | a | 3,585 | direct | |
| 2018-09-30 | A | 534 | a | 9,332 | direct | |
| 2018-09-03 | F | 273 | d | 15,222 | direct | |
| 2018-09-03 | M | 797 | a | 15,495 | direct | |
| 2018-09-03 | M | 797 | d | 0 | direct | |
| 2018-09-01 | M | 641 | a | 4,057 | direct | |
| 2018-09-01 | M | 641 | d | 1,283 | direct | |
| 2018-09-01 | F | 220 | d | 3,837 | direct |
